S

Seattle Allergy and Asthma Research Institute | Seattle, WA

Research site

(Unclaimed)

Location

9725 Third Avenue NE, Suite 500, Seattle, Washington, United States of America

Site insights

Top conditions

Top treatments

Dupilumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis (ENGAGE)

The study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or...

Enrolling

Eosinophilic Gastrointestinal Disease

Eosinophilic Gastritis

Drug: Dupilumab Dose 2

Drug: Matching Placebo

Allergic Disease Onset Prevention Study (adored)

This is a Phase 1b/2, randomized, double-blind, multi-center study to evaluate the safety, tolerability, and preliminary clinical efficacy of STMC-10...

Active, not recruiting

Atopic Dermatitis

Type 1 Hypersensitivity

Biological: STMC-103H

Biological: Placebo

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms